Unlike IL-1, which has dual effects, IL-6 is a prototypical protumorigenic cytokine that promotes chronic inflammation while supporting tumor angiogenesis and inhibiting Th1 cell-mediated antitumor immunity (68, 69). Here, IL6 is linked to neoplasm.